RTW Investments, LP 13D and 13G filings for Aptevo Therapeutics Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
2023-02-14 10:15 am Sale |
2021-12-31 | 13G | Aptevo Therapeutics Inc. APVO |
RTW Investments, LP | 0 0.000% |
-177![]() (Position Closed) |
Filing |
2021-02-12 09:25 am Sale |
2020-12-31 | 13G | Aptevo Therapeutics Inc. APVO |
RTW Investments, LP | 177 6.960% |
-1![]() (-0.61%) |
Filing |
2020-11-16 11:02 am Purchase |
2020-11-05 | 13G | Aptevo Therapeutics Inc. APVO |
RTW Investments, LP | 178 8.970% |
178![]() (New Position) |
Filing |